Brind.
  1. Cogent Biosciences plans to submit an NDA to the FDA, with Andrew Robbins as President and CEO.

FDA acceptance of NDA supports drug development.

1 report, 1 independent Updated Sep 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

FDA acceptance of NDA supports drug development.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped